ARTICLE | Company News
Bioton, Medipolis deal
September 24, 2012 7:00 AM UTC
CMO Medipolis granted Bioton rights to a biosimilar insulin analog manufacturing technology. Medipolis said the deal is worth €5.3 million ($6.9 million). The companies declined to disclose details. ...